Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 251–275 of 7,816 matching trials · page 11 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Just-In-Time Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration
NCT05145868
Alcohol Skills and Emotion Regulation Intervention; Attention Control
Runs in: United States · 1 site
NA
other
ACTIVE_NOT_RECRUITING 400 Georgia State University
OTHER
2026-08-27
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment
NCT05601583
Continuous Glucose Monitor (CGM)
Runs in: United States · 1 site
PHASE1
other
COMPLETED 14 NYU Langone Health
OTHER
2026-08-27
ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria
NCT06782230
Runs in: Italy · 1 site
NA
other
RECRUITING 800 IRCCS Policlinico S. Donato
OTHER
2026-08-27
Effectiveness of a Smartphone App (PRIMI) to Promote Healthy Diet and Physical Activity After Pregnancy in Migrant Women
NCT06881277
Mobile phone based intervention
Runs in: Sweden · 1 site
NA
other
RECRUITING 200 Linkoeping University
OTHER_GOV
2026-08-27
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192
ML-007C-MA; Placebo
Runs in: Argentina; Bulgaria; Canada; Czechia; France; Hungary; It... · 55 sites
PHASE2
other
RECRUITING 300 MapLight Therapeutics
INDUSTRY
2026-08-27
Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in China
NCT07601516
Deutetrabenazine
Runs in: China · 3 sites
PHASE4
other
COMPLETED 50 Teva Branded Pharmaceutical Products R&D LLC
INDUSTRY
2026-08-27
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
NCT07787169
LY4405094; LY4405094; Placebo; Placebo; Florbetapir F18; Florbetaben F 18
Runs in: United States · 10 sites
PHASE1
other
NOT_YET_RECRUITING 179 Eli Lilly and Company
INDUSTRY
2026-08-27
Just-in-Time Coping Prompts for Reactive Digital Behavior in College Students
NCT07789314
Momentary coping prompt; Active control message
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 80 University of Florida
OTHER
2026-08-27
A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease
NCT07789873
GAL-101 Salt; Placebo
PHASE2
other
NOT_YET_RECRUITING 100 Galimedix Therapeutics Inc
INDUSTRY
2026-08-27
Screening for Memory Studies
NCT01123018
Memtrax Memory screening test
Runs in: United States · 1 site
NA
other
COMPLETED 1 John Wesson Ashford Jr
OTHER_GOV
2026-08-26
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511
Donanemab; Placebo
Runs in: Australia; Canada; Czechia; Japan; Netherlands; Poland; P... · 274 sites
PHASE3
anti-amyloid-antibody
ACTIVE_NOT_RECRUITING 1,736 Eli Lilly and Company
INDUSTRY
2026-08-26
BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart)
NCT06061406
smart visit app
Runs in: Germany · 1 site
NA
other
COMPLETED 100 Wuerzburg University Hospital
OTHER
2026-08-26
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787
KarXT; Placebo
Runs in: Argentina; Belgium; Brazil; Bulgaria; China; Croatia; Fra... · 293 sites
PHASE3
other
RECRUITING 406 Karuna Therapeutics, Inc., a Bristol Myers Squibb company
INDUSTRY
2026-08-26
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT06651567
ITI-1284; Placebo
Runs in: Bulgaria; Croatia; Czechia; Romania; Serbia; Slovakia; Sp... · 70 sites
PHASE2
other
RECRUITING 320 Intra-Cellular Therapies, Inc.
INDUSTRY
2026-08-26
Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment and Early Alzheimer's Disease
NCT06767124
Ketogenic Supplement; Placebo Drink
Runs in: Canada · 1 site
NA
other
NOT_YET_RECRUITING 17 University of Pennsylvania
OTHER
2026-08-26
[18F]ACI-19626 PET in TDP-43 Proteinopathies
NCT06891716
[18F]ACI-19626
Runs in: Netherlands · 1 site
EARLY_PHASE1
other
RECRUITING 45 AC Immune SA
INDUSTRY
2026-08-26
The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moderate Dementia
NCT07033468
VR-WLC; CTL-VR
Runs in: Taiwan · 1 site
NA
other
RECRUITING 60 Chang Gung Memorial Hospital
OTHER
2026-08-26
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494
MK-2214; Placebo
Runs in: Argentina; Australia; Belgium; Canada; Japan; Netherlands... · 80 sites
PHASE2
other
RECRUITING 340 Merck Sharp & Dohme LLC
INDUSTRY
2026-08-26
Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease
NCT07205601
RB-ADSC; Placebo
PHASE2
other
NOT_YET_RECRUITING 115 Regeneration Biomedical, Inc.
INDUSTRY
2026-08-26
Dyadic, App-supported Collaborative Care Intervention Trial for Family Caregivers of People Living With Dementia
NCT07251088
Experimental arm
Runs in: Germany · 12 sites
NA
other
RECRUITING 554 German Center for Neurodegenerative Diseases (DZNE)
OTHER
2026-08-26
Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02
NCT07373067
RB-ADSC
PHASE1
other
NOT_YET_RECRUITING 9 Regeneration Biomedical, Inc.
INDUSTRY
2026-08-26
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182
LY4405094; LY4405094; Placebo; Placebo; Florbetapir F18; Florbetaben F 18
Runs in: United States · 10 sites
PHASE1
other
NOT_YET_RECRUITING 68 Eli Lilly and Company
INDUSTRY
2026-08-26
Effect of Virtual Reality on Agitation in Acute Stroke
NCT07787910
Virtual Reality Application; Standard Care (in control arm)
Runs in: Turkey (Türkiye) · 1 site
NA
other
COMPLETED 68 Ankara Etlik City Hospital
OTHER_GOV
2026-08-26
An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease
NCT04514367
ANX005
Runs in: United States · 6 sites
PHASE2
other
COMPLETED 28 Annexon, Inc.
INDUSTRY
2026-08-25
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
NCT04852601
ToolboxDetect
Runs in: United States · 1 site
NA
other
COMPLETED 35,403 Northwestern University
OTHER
2026-08-25

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →